BIBF 1120/nintedanib: A new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
Article
Rolfo, C, Raez, LE, Bronte, G et al. (2013). BIBF 1120/nintedanib: A new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22(8), 1081-1088. 10.1517/13543784.2013.812630
Rolfo, C, Raez, LE, Bronte, G et al. (2013). BIBF 1120/nintedanib: A new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22(8), 1081-1088. 10.1517/13543784.2013.812630